Real-world external control arm for the single-arm LIBRETTO-001 trial of selpercatinib in RET-mutation-positive medullary thyroid cancer: RECALIB-RET
在RET突变阳性甲状腺髓样癌患者中，针对selpercatinib的单臂LIBRETTO-001试验的真实世界外部对照组：RECALIB-RET
期刊:ESMO Open
影响因子:8.3
doi:10.1016/j.esmoop.2026.106083
Hadoux, J; Hernando, J; Wong, K H; Do Cao, C; Lasolle, H; Buffet, C; Benisvy, D; Illouz, F; Schneegans, O; Varnier, R; Drui, D; Zanetta, S; Hescot, S; Muller, M; Nascimento, C; Roudaut, N; Khanal, M; Zheng, S; Li, X; Singh, R; Tian, W; Afonso, A S; Houot, B; Borget, I; Segall, G
